Abstract
Polycystic ovary syndrome (PCOS) appears to be related to sexual dysfunction, especially if associated with obvious clinical and hormonal signs of hyperandrogenism. The objective of this study was to determine the correlation of PCOS and its hormonal and clinical parameters with sexual function. This prospective, cross-sectional study conducted on 18–45-year-old PCOS women (according to the Rotterdam criteria), who were referred to the Reproductive Endocrinology Research Center, Iran, was invited to participate from January 2012 to December 2015. The Female Sexual Function Index (FSFI) was used to evaluate sexual function, and serum levels of total and free testosterone, androstenedione, and sex hormone-binding globulin (SHBG) were determined and employed to calculate free androgen index (FAI) values. Univariate and multiple logistic regression analyses were performed to examine the association between sexual dysfunction and independent variables. In all, 783 participated in the study and 492 women fully completed the Female Sexual Function Index (FSFI) questionnaire. Of these, 226 (45.75%) women met the criteria for sexual dysfunction. The mean age of women was 24.91 ± 4.90 years. No significant association between having a low score for any FSFI domain and having a low serum total or free testosterone or androstenedione and SHBG level was demonstrated. There was association between FAI > 4.5 and increased sexual function score but it is not significant. Logistic regression analysis showed that there were significant associations between sexual function score and the literacy, alopecia, and infertility. No evidence of associations between low scores for any of the sexual domains evaluated and low serum total and free testosterone levels, but the low literacy, alopecia, and infertility contributed to low sexual function in women with PCOS. The burden of PCOS and sexual dysfunction suggests the need for further attention to this patient population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97:28–38. e25
Sirmans SM, Parish RC, Blake S, Wang X. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population. J Invest Med. 2014;62:868–74.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39.
McCook JG, Reame NE, Thatcher SS. Health‐related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2005;34:12–20.
Goolsby MJ. AACE hyperandrogenism guidelines. J Am Acad Nurse Pract. 2001;13:492.
Hunter MH, Sterrett JJ. Polycystic ovary syndrome: it’s not just infertility. Am Fam Phys. 2000;62:1079–88. 90
Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS) 1. J Clin Endocrinol Metab. 1998;83:1976–87.
Elizabeth M, Leslie NS, Critch EA. Managing polycystic ovary syndrome: a cognitive behavioral strategy. Nurs Womens Health. 2009;13:292–300.
Duncan WC. A guide to understanding polycystic ovary syndrome (PCOS). J Fam Plann Reprod Health Care. 2014;40:217–25.
Reis SL, Abdo CH. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors. Clinics (Sao Paulo). 2014;69:294–303.
Elsenbruch S, Hahn S, Kowalsky D, Öffner AH, Schedlowski M, Mann K, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:5801–7.
Ferraresi SR, Lara L, Reis RM, de Sá Rosa-e-Silva ACJ. Changes in sexual function among women with polycystic ovary syndrome: a pilot study. J Sex Med. 2013;10:467–73
Veras AB, Bruno RV, de Avila MAP, Nardi AE. Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations. Comprehensive psychiatry. 2011;52:486–9
Månsson M, Norström K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landén M. Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Bio. 2011;155:161–5.
Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S, editors. Mood and sexual function in polycystic ovary syndrome. Semin Reprod Med. 2008; 26:45-52.
ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
Hayashi N, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J Dermatol. 2008;35:255–60.
De Niet J, De Koning C, Pastoor H, Duivenvoorden H, Valkenburg O, Ramakers M, et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod. 2010;25:1497–503.
Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. American journal of obstetrics and gynecology. 1981;140:815–30.
Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clinical Endocrinol Metabol. 2004;89:525–33.
Rosen CB, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.
Mohammadi K, Heydari M, Faghihzadeh S. The female sexual function index (FSFI): validation of the Iranian version. 2008; 7:269-278.
Khademi A, Alleyassin A, Agha-hosseini M, Dadras N, Asghari Roodsari A, Tabatabaeefar L, et al. Psychometric properties of Sexual Function Questionnaire: evaluation of an Iranian sample. Iran J Reprod Med. 2006;4:23–8.
Wierman ME, Nappi RE, Avis N, Davis SR, Labrie F, Rosner W, et al. Endocrine aspects of women’s sexual function. J Sex Med. 2010;7:561–85.
Hashemi S, Ramezani Tehrani F, Farahmand M, Bahri Khomami M. Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS. J Sex Med. 2014;11:2508–14.
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153:853–60.
Lara LA, Ramos FK, Kogure GS, Costa RS, Silva de Sa MF, Ferriani RA, et al. Impact of physical resistance training on the sexual function of women with polycystic ovary Syndrome. J Sex Med. 2015;12:1584–90.
Zueff LN, Lara LA, Vieira CS, Martins Wde P, Ferriani RA. Body composition characteristics predict sexual functioning in obese women with or without PCOS. J Sex Marital Ther. 2015;41:227–37.
Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour Thamtan RA. The experience of women affected by polycystic ovary syndrome: a qualitative study from Iran. Int J Endocrinol Metab. 2014;12:e13612.
Millheiser LS, Helmer AE, Quintero RB, Westphal LM, Milki AA, Lathi RB. Is infertility a risk factor for female sexual dysfunction? A case-control study. Fertil Steril. 2010;94:2022–5.
Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv. 2006;61:723–32.
Monga M, Alexandrescu B, Katz SE, Stein M, Ganiats T. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 2004;63:126–30.
Bakhtiari A, Basirat Z, Nasiri-Amiri F. Sexual dysfunction in women undergoing fertility treatment in Iran: prevalence and associated risk factors. J Reprod Infertil. 2016;17:26–33.
Drosdzol A, Skrzypulec V. Quality of life and sexual functioning of Polish infertile couples. Eur J Contracept Reprod Health Care. 2008;13:271–81.
Iris A, Aydogan Kirmizi D, Taner CE. Effects of infertility and infertility duration on female sexual functions. Arch Gynecol Obstet. 2013;287:809–12.
Nasiri-Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour RA. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties. Qual Life Res. 2016; 25:1791-1801.
Weiss TR, Bulmer SM. Young women’s experiences living with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2011;40:709–18.
Kitzinger C, Willmott J. ‘The thief of womanhood’: women’s experience of polycystic ovarian syndrome. Soc Sci Med. 2002;54:349–61.
Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Thamtan RA, Shiva N. Female fender scheme is disturbed by polycystic ovary syndrome: a qualitative study from Iran. Iran Red Crescent Med J. 2014;16:e12423.
Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod. 2008;23:2064–71.
Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod. 2006;21:1925–34.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.
Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294:91–6.
Echeverry MC, Arango A, Castro B, Raigosa G. Study of the prevalence of female sexual dysfunction in sexually active women 18 to 40 years of age in Medellin, Colombia. J Sex Med. 2010;7:2663–9.
Jafarzadeh Esfehani R, Fazel N, Dashti S, Moshkani S, Haghighi Hasanabad F, Foji S, et al. Female sexual dysfunction and its associated risk factors: an epidemiological study in the north-east of Iran. J Midwifery Reprod Health. 2016;4:498–505.
Goldstein I, Meston CM, Davis S, Traish A. Women’s sexual function and dysfunction: study, diagnosis and treatment. CRC Press; London and New York, Taylor & Francis Group, ISBN1842142631, 2005.
Acknowledgments
We are indebted to each of the study participants for the substantial time and effort they contributed to this study. The authors also thank the Research Institute for Endocrine Sciences and Babol University of Medical Sciences, Iran for the approval of this project.
Author Contributions
F.N.A. and F.R.T. contributed to the project development, data collection, manuscript writing and critical discussion. S.E. and Z.B. contributed to the manuscript writing and critical discussion. M.T. contributed to the laboratory analysis and manuscript writing. F.A. contributed to the project development and manuscript drafting. All authors were involved in the preparation of the manuscript and approved the final manuscript.
Funding
This study was funded by the Research Institute for Endocrine Sciences (Grant number 390) and Babol University of Medical Sciences (Grant number 9133715).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethical approval
The ethical review boards of the Research Institute for Endocrine Sciences and the Babol University of Medical Sciences have approved the study proposal. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Shahid Beheshti University of Medical Sciences Research Committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Nasiri Amiri, F., Ramezani Tehrani, F., Esmailzadeh, S. et al. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res 30, 54–61 (2018). https://doi.org/10.1038/s41443-017-0006-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41443-017-0006-2
This article is cited by
-
Association of hirsutism and anthropometric profiles with sexual dysfunction and anxiety levels in infertile Indonesian women with polycystic ovarian syndrome
Middle East Fertility Society Journal (2024)
-
Predictive factors of Sexual Quality of Life in women with polycystic ovary syndrome: a path analysis
International Journal of Impotence Research (2023)
-
Sessualità e sindrome dell’ovaio policistico
L'Endocrinologo (2023)
-
Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation
BMC Women's Health (2020)
-
Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis
Hormones (2020)